Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Sfikakis

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
European Journal of Clinical Investigation|June 14, 2005
Age-related thymic activity in adults following chemotherapy-induced lymphopeniaP P Sfikakis, G M Gourgoulis, L A Moulopoulos, et al.
Clinical Immunology and Immunopathology|February 1, 1995
Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosusS Theocharis, P P Sfikakis, R N Lipnick, et al.
Rheumatology (Oxford, England)|July 8, 2008
Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective studyG Karanikolas, D Charalambopoulos, G Vaiopoulos, et al.
Scandinavian Journal of Rheumatology|February 21, 2009
Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitisI Moyssakis, E Gialafos, V A Vassiliou, et al.
Clinical Immunology and Immunopathology|April 1, 1996
Downregulation of interleukin-2 and apha-chain interleukin-2 receptor biosynthesis by cisplatin in human peripheral lymphocytesP P Sfikakis, V L Souliotis, N Katsilambros, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|April 6, 2001
B-cell kinase lyn deficiency in patients with systemic lupus erythematosusS N Liossis, E E Solomou, M A Dimopoulos, et al.
Annals of Internal Medicine|March 5, 2004
Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet diseaseP P Sfikakis, P H Kaklamanis, A Elezoglou, et al.
Arthritis and Rheumatism|February 5, 2005
Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trialP P Sfikakis, J N Boletis, S Lionaki, et al.
Clinical Immunology (Orlando, Fla.)|February 6, 2007
Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritisP P Sfikakis, V L Souliotis, K G Fragiadaki, et al.
Calcified Tissue International|October 1, 1991
Clinical and laboratory parameters in adult diabetics with and without calcific shoulder periarthritisM E Mavrikakis, P P Sfikakis, S A Kontoyannis, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
European Journal of Clinical Investigation|June 14, 2005
Age-related thymic activity in adults following chemotherapy-induced lymphopeniaP P Sfikakis, G M Gourgoulis, L A Moulopoulos, et al.
Clinical Immunology and Immunopathology|February 1, 1995
Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosusS Theocharis, P P Sfikakis, R N Lipnick, et al.
Rheumatology (Oxford, England)|July 8, 2008
Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective studyG Karanikolas, D Charalambopoulos, G Vaiopoulos, et al.
Scandinavian Journal of Rheumatology|February 21, 2009
Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitisI Moyssakis, E Gialafos, V A Vassiliou, et al.
Clinical Immunology and Immunopathology|April 1, 1996
Downregulation of interleukin-2 and apha-chain interleukin-2 receptor biosynthesis by cisplatin in human peripheral lymphocytesP P Sfikakis, V L Souliotis, N Katsilambros, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|April 6, 2001
B-cell kinase lyn deficiency in patients with systemic lupus erythematosusS N Liossis, E E Solomou, M A Dimopoulos, et al.
Annals of Internal Medicine|March 5, 2004
Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet diseaseP P Sfikakis, P H Kaklamanis, A Elezoglou, et al.
Arthritis and Rheumatism|February 5, 2005
Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trialP P Sfikakis, J N Boletis, S Lionaki, et al.
Clinical Immunology (Orlando, Fla.)|February 6, 2007
Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritisP P Sfikakis, V L Souliotis, K G Fragiadaki, et al.
Calcified Tissue International|October 1, 1991
Clinical and laboratory parameters in adult diabetics with and without calcific shoulder periarthritisM E Mavrikakis, P P Sfikakis, S A Kontoyannis, et al.
Pageof 11